whi p154 has been researched along with 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, JD; Golshayan, D; Juillerat-Jeanneret, L; Mikulic, J | 1 |
1 review(s) available for whi p154 and 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
Article | Year |
---|---|
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction.
Topics: Animals; Drug Discovery; Fibrosis; Humans; Molecular Targeted Therapy; Organ Specificity | 2018 |